£169.49

Horizons in Cancer Research: Volume 78 (Horizons in Cancer Research)

Price data last checked 36 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£169 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 55 days · 55 data points (no recent data)

Historical
Generating forecast…
£173.50 £169.09 £170.05 £171.01 £171.98 £172.94 £173.90 14 April 2026 27 April 2026 11 May 2026 24 May 2026 07 June 2026

Price Distribution

Price distribution over 55 days • 2 price levels

Days at Price
Current Price
5 days · current 50 days 0 13 25 38 50 £169 £174 Days at Price

Price Analysis

Most common price: £174 (50 days, 90.9%)

Price range: £169 - £174

Price levels: 2 different prices over 55 days

Description

This compilation begins by discussing the common pediatric brain tumors, their key oncogenic drivers and signaling pathways. An update on the clinical trials against druggable targets is also provided. An outline of the metabolizing pathways in cancer and the mode of action of aerobic glycolysis in cancer cells is presented, also highlighting the roles of nanotechnology in energy-based cancer therapies. The authors review recent studies that characterize the specific mechanisms involved in mediating -tocotrienol reversal of epithelial-to mesenchymal transition in malignant breast cancer cells. The cytotoxic effects of Mannich bases derived from kojic acid on A375 human malignant melanoma are discussed and MRC-5 human lung cell lines are investigated using a sulphorhodamine B assay. Additionally, the cytotoxic effects and mechanisms displayed by metformin are assessed, alone or in combination with other agents. A better understanding of metformin-induced metabolic changes could aid in the discovery of new drugs, enhancing the efficacy of current melanoma therapeutics. In closing, the authors explore the way in which physical activity and exercise are negatively correlated to most type of cancers, as exercise shares common underlying metabolic pathways with those of some bioactive food compounds, such as polyphenols.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
04 November 2020
Listed Since
15 October 2020

Barcode

No barcode data available

Similar Products You Might Like

Horizons in Cancer Research: v. 41: Volume 41
81% match

Horizons in Cancer Research: v. 41: Volume 41

£133.51 08 Jun 2026
New Topics in Cancer Research (Horizons in Cancer Research)
81% match

New Topics in Cancer Research (Horizons in Cancer Research)

Brand: Nova Biomedical Books

£140.62 31 May 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
80% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 31 May 2026
Exercise, Energy Balance, and Cancer: 6
80% match

Exercise, Energy Balance, and Cancer: 6

Springer

£107.98 30 May 2026
Exercise, Energy Balance, and Cancer: 6
80% match

Exercise, Energy Balance, and Cancer: 6

Springer

£106.16 05 Jun 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
79% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.39 26 May 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
79% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 05 Jun 2026
Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)
79% match

Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)

Springer

£113.76 03 Jul 2026
Horizons in Cancer Research. Volume 81 (Horizons in Cancer Research)
79% match

Horizons in Cancer Research. Volume 81 (Horizons in Cancer Research)

£169.49 12 Jun 2026
Tumor Cell Metabolism: Pathways, Regulation and Biology
79% match

Tumor Cell Metabolism: Pathways, Regulation and Biology

Springer

£76.38 24 May 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
78% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 25 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
78% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 24 May 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
78% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£163.85 31 May 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
78% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.05 25 May 2026
New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)
78% match

New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)

Springer

£129.15 24 Jun 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
78% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 25 May 2026
Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices
78% match

Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices

Academic Press

£119.82 06 Jun 2026
Malignant Melanoma 1: 9 (Cancer Treatment and Research, 9)
78% match

Malignant Melanoma 1: 9 (Cancer Treatment and Research, 9)

Springer

£125.96 05 Jun 2026
Gynecologic Oncology: Controversies and New Developments: 70 (Cancer Treatment and Research, 70)
78% match

Gynecologic Oncology: Controversies and New Developments: 70 (Cancer Treatment and Research, 70)

Springer

£113.76 28 May 2026
Molecular Pathogenesis of Colorectal Cancer
78% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£107.98 28 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
78% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.40 28 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
78% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£163.14 30 May 2026
Therapy for Genitourinary Cancer: 59 (Cancer Treatment and Research, 59)
78% match

Therapy for Genitourinary Cancer: 59 (Cancer Treatment and Research, 59)

Springer

£129.20 31 May 2026
Molecular Targeted Therapy of Lung Cancer
77% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.70 06 Jun 2026